Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human KCNJ14 ELISA Kit (AC3360)
Cat.#: ASET-1949
Specifications
Description Human KCNJ14 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNJ14 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 8.84 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2232 Rat GCLM ELISA Kit (AC3643) Quantitative inquiry ASET-1635 Mouse CX3CR1 ELISA Kit (AC3046) Quantitative inquiry ASET-1022 Human Neurexin 1 ELISA Kit (AC2433) Quantitative inquiry ASET-1782 Mouse Dopamine Transporter ELISA Kit (AC3193) Quantitative inquiry ASET-1412 Human UNC5D ELISA Kit (AC2823) Quantitative inquiry ASET-2295 Rat GABA ELISA Kit (AC3706) Quantitative inquiry ASET-1989 Mouse FGF2 ELISA Kit (AC3400) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-2306 Human Syndecan 4 ELISA Kit (AC3717) Quantitative inquiry ASET-2527 Human Chromogranin A ELISA Kit (AC3938) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket